Skip to main content
Tech.euFundingExplorerBeta

BioCorteX

Carbon Mirror platform which is a computer simulation to understand drug-bacteria interactions which hopes to improve a person's response to treatments

BioCorteX has raised €4.6M across 1 funding round from 2 investors, most recently a Seed round in Mar 2023. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€4.6M
€4,597,701
Funding rounds
1
Investors
2
distinct backers
Active since
2023-03
latest 2023-03

Funding by year

EUR raised per year
BioCorteX — funding by year — interactive chart.
Data table
BioCorteX — funding by year
2023€4.6M

Signals

High confidence
Raise-next likelihood9
base rate 44% for Seed
  • ▼ Past typical raise window

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2023-03-31Seed€4.6MHoxton Ventures,Sofinnova PartnersView deal →

Related news

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData